메뉴 건너뛰기




Volumn 49, Issue 7, 2011, Pages 2394-2397

Point-counterpoint

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANTIGEN DETECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ESCHERICHIA COLI INFECTION; FECES CULTURE; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEASONAL VARIATION; SEROTYPING; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SUMMER; SYNDROME DELINEATION; CHEMISTRY; CULTURE MEDIUM; ECONOMICS; FECES; IMMUNOASSAY; INCIDENCE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MORTALITY; NOTE; PREVALENCE; PUBLIC HEALTH SERVICE; UNITED STATES;

EID: 80053105000     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (8)

References (17)
  • 2
    • 0035877769 scopus 로고    scopus 로고
    • University outbreak of calicivirus infection mistakenly attributed to Shiga toxin-producing Escherichia coli O157:H7-Virginia, 2000
    • CDC
    • CDC. 2001. University outbreak of calicivirus infection mistakenly attributed to Shiga toxin-producing Escherichia coli O157:H7-Virginia, 2000. MMWR Morb. Mortal. Wkly. Rep. 50:489-491.
    • (2001) MMWR Morb. Mortal. Wkly. Rep. , vol.50 , pp. 489-491
  • 3
    • 33749125204 scopus 로고    scopus 로고
    • Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis - New York and North Carolina, 2005
    • CDC
    • CDC. 2006. Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis - New York and North Carolina, 2005. MMWR Morb. Mortal. Wkly. Rep. 55:1042-1045.
    • (2006) MMWR Morb. Mortal. Wkly. Rep. , vol.55 , pp. 1042-1045
  • 4
    • 70350041489 scopus 로고    scopus 로고
    • Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories
    • CDC
    • CDC. 2009. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Morb. Mortal. Wkly. Rep. 58:1-14.
    • (2009) MMWR Morb. Mortal. Wkly. Rep. , vol.58 , pp. 1-14
  • 5
    • 16544385639 scopus 로고    scopus 로고
    • Evaluation of Performance and Potential Clinical Impact of ProSpecT Shiga Toxin Escherichia coli Microplate Assay for Detection of Shiga Toxin-Producing E. coli in Stool Samples
    • DOI 10.1128/JCM.42.4.1652-1656.2004
    • Gavin, P. J., et al. 2004. Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga toxin-producing E. coli in stool samples. J. Clin. Microbiol. 42:1652-1656. (Pubitemid 38500812)
    • (2004) Journal of Clinical Microbiology , vol.42 , Issue.4 , pp. 1652-1656
    • Gavin, P.J.1    Peterson, L.R.2    Pasquariello, A.C.3    Blackburn, J.4    Hamming, M.G.5    Kuo, K.J.6    Thomson Jr., R.B.7
  • 6
    • 33845388167 scopus 로고    scopus 로고
    • The emerging clinical importance of non-O157 shiga toxin-producing Escherichia coli
    • DOI 10.1086/509573
    • Johnson, K. E., C. M. Thorpe, and C. L. Sears. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595. (Pubitemid 44901903)
    • (2006) Clinical Infectious Diseases , vol.43 , Issue.12 , pp. 1587-1595
    • Johnson, K.E.1    Thorpe, C.M.2    Sears, C.L.3
  • 7
    • 68049113595 scopus 로고    scopus 로고
    • Shiga toxin-producing Escherichia coli, New Mexico, USA, 2004-2007
    • Lathrop, S., K., Edge, and J. Bareta. 2009. Shiga toxin-producing Escherichia coli, New Mexico, USA, 2004-2007. Emerg. Infect. Dis. 15:1289-1291.
    • (2009) Emerg. Infect. Dis. , vol.15 , pp. 1289-1291
    • Lathrop, S.1    Edge, K.2    Bareta, J.3
  • 9
    • 84859971157 scopus 로고    scopus 로고
    • Clinical manifestations and diagnosis of Shiga-like toxin associated (typical) hemolytic uremic syndrome in children
    • T. J. Mattoo and S. L. Kaplan (ed.). Waltham, MA
    • Niaudet, P. 2010. Clinical manifestations and diagnosis of Shiga-like toxin associated (typical) hemolytic uremic syndrome in children. In T. J. Mattoo and S. L. Kaplan (ed.). UpToDate, Waltham, MA.
    • (2010) UpToDate
    • Niaudet, P.1
  • 10
    • 33645726250 scopus 로고    scopus 로고
    • Continuous surveillance of Shiga toxin-producing Escherichia coli infections by pulsed-field gel electrophoresis shows that most infections are sporadic
    • Nielsen, E. M., F. Scheutz, and M. Torpdahl. 2006. Continuous surveillance of Shiga toxin-producing Escherichia coli infections by pulsed-field gel electrophoresis shows that most infections are sporadic. Food Pathog. Dis. 3:81-87.
    • (2006) Food Pathog. Dis. , vol.3 , pp. 81-87
    • Nielsen, E.M.1    Scheutz, F.2    Torpdahl, M.3
  • 11
    • 33747343667 scopus 로고    scopus 로고
    • Are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?
    • Panos, G. Z., G. I. Betsi, and M. E. Falagas. 2006. Are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Alim. Pharmacol. 24:731-742.
    • (2006) Alim. Pharmacol. , vol.24 , pp. 731-742
    • Panos, G.Z.1    Betsi, G.I.2    Falagas, M.E.3
  • 13
    • 65449169748 scopus 로고    scopus 로고
    • From diarrhoea to haemolytic uraemic syndrome - When to seek advice
    • Pollock, K. G. et al. 2009. From diarrhoea to haemolytic uraemic syndrome - when to seek advice. J. Med. Microbiol. 58:397-398.
    • (2009) J. Med. Microbiol. , vol.58 , pp. 397-398
    • Pollock, K.G.1
  • 14
    • 0037190096 scopus 로고    scopus 로고
    • Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: A meta-analysis
    • Safdar, N., A. Said, R. E. Gangnon, and D. G. Maki, 2002. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis. J. Am. Med. Assoc. 288:996-1001. (Pubitemid 34920465)
    • (2002) Journal of the American Medical Association , vol.288 , Issue.8 , pp. 996-1001
    • Safdar, N.1    Said, A.2    Gangnon, R.E.3    Maki, D.G.4
  • 15
    • 70349777932 scopus 로고    scopus 로고
    • Primary and secondary cases in Escherichia coli O157 outbreaks: A statistical analysis
    • Snedeker, K. G., D. J. Shaw, M. E. Locking, and R. J. Prescott. 2009. Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infect. Dis. 9:144-154.
    • (2009) BMC Infect. Dis. , vol.9 , pp. 144-154
    • Snedeker, K.G.1    Shaw, D.J.2    Locking, M.E.3    Prescott, R.J.4
  • 16
    • 15244348050 scopus 로고    scopus 로고
    • Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
    • DOI 10.1016/S0140-6736(05)71144-2
    • Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086. (Pubitemid 40386785)
    • (2005) Lancet , vol.365 , Issue.9464 , pp. 1073-1086
    • Tarr, P.I.1    Gordon, C.A.2    Chandler, W.L.3
  • 17
    • 42549165230 scopus 로고    scopus 로고
    • Preventing household transmission of shiga toxin-producing Escherichia coli O157 infection: Promptly separating siblings might be the key
    • DOI 10.1086/587670
    • Werber, D., B. W. Mason, M. R. Evans, and R. L. Salmon. 2008. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be key. Clin. Infect. Dis. 46:1189-1196. (Pubitemid 351589901)
    • (2008) Clinical Infectious Diseases , vol.46 , Issue.8 , pp. 1189-1196
    • Werber, D.1    Mason, B.W.2    Evans, M.R.3    Salmon, R.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.